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conflicAbstract—When calcification, frequently found in both benign and malignant nodules, is present in thyroid nod-
ules, non-invasive differentiation with ultrasound becomes challenging. The goal of this study was to evaluate the
utility of elastography in differentiating calcified thyroid nodules. Consecutive patients (165 patients with 196 nod-
ules) referred for fine-needle aspiration who had undergone both ultrasound elastography and B-mode examina-
tions were analyzed retrospectively. Calcification was present in 45 benign and 20 malignant nodules. On 65
calcified nodules, elastography had 95% sensitivity, 51.1% specificity, 46.3% positive predictive value and
95.8% negative predictive value in detecting malignancy. Twenty-three of 45 benign calcified nodules were
correctly diagnosed with elastography compared with 4 of 45 by B-mode ultrasound. Although it is difficult to
differentiate benign and malignant calcified thyroid nodules solely with B-mode ultrasound, elastography has
the potential to reduce the number of fine-needle aspiration biopsies performed on calcified nodules. (E-mail:
ldj6026@catholic.ac.kr)  2014 World Federation for Ultrasound in Medicine & Biology.
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Calcification is a key ultrasound (US) feature suggesting
malignancy of thyroid nodules (Kim et al. 2002; Moon
et al. 2008; Papini et al. 2002). Current major guidelines
(Cooper et al. 2009; Gharib et al. 2010; Moon et al.
2011) strongly recommended that a calcified nodule
larger than 5 mm be biopsied. Calcification is frequently
detected in thyroid nodules: 19.8%–41.3% of thyroid
nodules have calcification (Kakkos et al. 2000; Khoo
et al. 2002; Moon et al. 2008; Seiberling et al. 2004;
Wang et al. 2006; Watters et al. 1992). Also,
calcification can occur in both benign (17%–38.7%) and
malignant (26.1%–78.8%) nodules, although it is more
frequently seen in malignant nodules (Kakkos et al.
2000; Khoo et al. 2002; Moon et al. 2008; Seiberlingddress correspondence to: Dong-Jun Lim, Division of Endocri-
and Metabolism, Department of Internal Medicine, Seoul St.
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2329et al. 2004; Wang et al. 2006; Watters et al. 1992).
Because it is difficult to differentiate benign and
malignant nodules with calcification on B-mode US
(Kim et al. 2013; Lu et al. 2011) and many thyroid
nodules have calcification, a large number of benign
calcified nodules are subjected to fine-needle aspiration
(FNA) biopsy. To reduce the number of FNA biopsies of
benign calcified nodules, a tool with a high negative pre-
dictive value for malignancy is desired.
Numerous studies have reported that US elastogra-
phy has high sensitivity and specificity in detecting
malignant thyroid nodules (Asteria et al. 2008;
Friedrich-Rust et al. 2010; Hong et al. 2009; Lyshchik
et al. 2005; Rago et al. 2007; Rubaltelli et al. 2009).
However, elastography is not widely used in clinical
practice to manage thyroid nodules. A major reason is
the lack of inter-observer agreement resulting from the
variability in elastography data acquisition and scoring
(Gharib et al. 2010; Unl€ut€urk et al. 2012). Compared
with elastography using external compression,
described in many previous studies, intrinsic comp-
ression elastography, in which carotid artery pulsation
is the internal compression source, has had significant
2330 Ultrasound in Medicine and Biology Volume 40, Number 10, 2014inter-observer and intra-observer agreement (Lim et al.
2012). However, whether intrinsic compression elastog-
raphy can effectively differentiate calcified benign and
malignant nodules has not been studied.
The aim of this study was to evaluate the role elas-
tography could play in managing thyroid nodules with
calcification.METHODS
Patients
One hundred eighty-eight patients (229 nodules)
referred to our institution (Seoul St. Mary’s Hospital,
The Catholic University of Korea) by primary care physi-
cians for a FNA biopsy from May 2011 to January 2012
were recruited for the study. After undergoing US and
elastography examinations, all patients underwent FNA
biopsy with laboratory tests regardless of the results of
elastography. Though repeated FNA biopsies were per-
formed on nodules with atypical cells of undetermined
significance or unsatisfactory results, 18 nodules were
excluded from the study because of inconclusive cytology
(n 5 9) or unsatisfactory (n 5 9) results during the study
period. Additionally, 9 cystic (.90% of content) and 6
dominant cystic (.50% of content) nodules, which
were classified based on recommendations (Moon et al.
2011), were also excluded. For patients withmultiple nod-
ules, only the nodule(s) that underwent FNA biopsy was
included in the study. In total, 196 nodules from 165 pa-
tients were included in this study, 62 from 31 patients
with multiple nodules and 134 from patients with single
nodules. Among them, 34 patients (20.6%) had undergone
surgery in our institution, and their histopathology results
were used as the final diagnosis of those nodules.
This study was approved by the institutional review
board of our institution, and all patients signed the
informed consent.B-Mode ultrasound imaging
B-Mode US images of thyroid nodules were ac-
quired using a commercial US machine (iU22, Philips
Medical Systems, Bothell, WA) with a 5- to 12-MHz
high-resolution linear probe. Retrospectively, a radiolo-
gist (with 15 y experience) whowas blind to the cytologic
and elastography results and the patient’s clinical infor-
mation examined the B-mode US images. Several
B-mode US features (echogenicity, margin, shape and
presence of calcification) were extracted. Echogenicity
was described as hyper-, iso-, hypo- or marked hypo-
echogenicity compared with the echogenicity of thyroid
parenchyma and strap muscle. Margins were described
as well-defined smooth, spiculated or ill-defined. Shape
was described as ovoid to round, irregular or taller than
wide, whereas calcification was categorized as micro-calcification, macro-calcification, rim calcification or no
calcification (Moon et al. 2008; Park et al. 2010). The
maximum diameter of three dimensions was used for
the analysis.
All thyroid nodules were classified into three groups
based on their B-mode US features: benign (group 1),
indeterminate (group 2) and suspicious for malignancy
(group 3). Nodules with one or more suspicious US
features indicative of malignancy (e.g., marked hypo-
echogenicity, ill-defined or spiculated margin, micro-
calcification, taller-than-wide shape) were classified as
suspicious for malignancy (group 3). Nodules were clas-
sified as benign (group 1) if there were no suspicious US
features. Nodules that could not be clearly classified as
either group 1 or group 3, because of the presence of
ambiguous US features, were classified as indeterminate
(group 2) (Moon et al. 2011; Park et al. 2010).
Real-time US elastography examination
Elastography examinations were performed by three
endocrinologists with more than 1 y of experience with
intrinsic compression elastography, using a commercial
US machine (Accuvix XG, Samsung Medison, Seoul,
Korea) with a L5-13 linear transducer. To perform an
elastography examination, the operator searched for a
transverse plane showing the common carotid artery;
the patient was then asked to hold his or her breath while
the US data were acquired (4 s). No external compres-
sion was applied during data acquisition as carotid artery
pulsation was used as an intrinsic compression source. A
quantitative scoring method (i.e., elasticity contrast index
[ECI]) described in our previous study (Luo et al. 2012)
was used. The ECI value was computed interactively
and displayed on the monitor of the US machine after
the nodule’s boundaries were delineated by the operator
(Lim et al. 2012; Luo et al. 2012).
For each nodule, a minimum of two elastography
measurements were made at the imaging plane on which
the largest diameter of the thyroid nodule was visible in
the transverse view. Additional measurements were
made on imaging planes exhibiting US characteristics
(e.g., echogenicity and presence of calcification) different
from those visible on the plane with the largest diameter.
A larger ECI value suggests a stiffer nodule, indicating an
increased likelihood of malignancy. In the presence of
multiple ECI values, the largest ECI value was used for
analysis.
Statistical data analysis
Levene’s test for normality was used to test the dis-
tribution of continuous variables. Normally distributed
and non-normally distributed variables are expressed as
the mean (standard deviation) and median (range) for
descriptive statistics, respectively. Nominal variables
Table 1. Baseline characteristics of the nodules
(N 5 196)
Size (mm) 11.09 6 5.83
Malignancy 42 (21.4%)
B-mode features
Taller-than-wide shape 38 (19.4%)
Spiculated margin 75 (38.3%)
Hypo-echogenicity 117 (59.7%)
Calcification 65 (33.2%)
Micro-calcification 26
Macro-calcification 7
Rim calcification 17
Mixed calcification 15
Elastography decreases number of FNA biopsies d M.-H. KIM et al. 2331were compared with the c2 test or Fisher’s exact test. The
independent t-test and Mann–Whitney U-test for un-
paired values were used for comparison of normally
distributed and non-normally distributed continuous vari-
ables, respectively.
To assess the diagnostic accuracy of US elastogra-
phy, we varied the ECI cutoff value and determined the
sensitivity and specificity combination that resulted in
the maximum geometric mean (i.e., [sensitivity 3
specificity]1/2) in detecting malignant nodules. The posi-
tive predictive value (PPV) and negative predictive value
(NPV) of elastography in the detection of malignant
nodule were also calculated.
All statistical analysis was performed using SPSS
12.0 (IBM, Chicago, IL, USA). A p-value , 0.05 was
considered to indicate statistical significance.RESULTS
Baseline characteristics of patients and nodules
There were 154 benign and 42 malignant nodules
from 165 patients (138 women, 27 men). All malignant
nodules were diagnosed as papillary thyroid carcinomas.
The median age of patients with malignant nodules (46
[range: 24–72]) did not significantly differ (p 5 0.193)
from that of patients with benign nodules (52 [23–78]).
There was no difference in gender between patients
with benign nodules and those with malignant nodules
(p 5 0.164).
The mean size of nodules was 11.09 6 5.83 mm.
Malignant nodules (9.10 6 4.17 mm) were significantly
(p 5 0.012) smaller than benign nodules (11.31 6
6.10 mm). There were 184 solid nodules and 12 dominant
solid nodules (solid in more than 50%). In 65 nodules
(33.2%) calcification was present as assessed by the radi-
ologist. Table 1 lists the numbers of nodules with each
suspicious B-mode US feature. All nodules were catego-
rized into three groups (benign, indeterminate and malig-
nant) on the basis of B-mode US features and two groups
(benign and malignant) on the basis of ECI values
(Table 2).Diagnostic performance of elastography
The mean ECI value of malignant nodules
(4.51 6 2.22) was significantly (p , 0.001) larger than
that of benign nodules (2.986 1.47). The sensitivity, spec-
ificity, PPVand NPVof elastography were 81.0%, 63.6%,
37.8% and 92.5% at an ECI cutoff value of 3.11. For nod-
ules ,1 cm (n 5 91, 65 benign and 26 malignant), the
sensitivity, specificity, PPV and NPV were 73.1%,
56.9%, 34.9% and 84.1% with elastography, respectively.
Higher diagnostic performance (sensitivity 5 93.8%,
specificity 5 68.5%, PPV 5 34.9%, NPV 5 98.4%)
was achieved with nodules $1 cm (n 5 105, 89 benignand 16 malignant) than with nodules ,1 cm. There were
8 false negatives (7 from non-calcified nodules, 1 from
calcified nodules) and 56 false positives (34 from non-
calcified nodules and 22 from calcified nodules) with
elastography.
Utility of elastography on calcified thyroid nodules
Among the nodules with calcification (n 5 65, 45
benign and 20 malignant), only 4 nodules were classified
as benign by the radiologist, and 3 of the 4 nodules were
found to be benign by elastography. On the basis of B-
mode ultrasound, 61 nodules were classified as either
indeterminate (n 5 29) or suspicious for malignancy
(n 5 32) by radiologist. As illustrated in Figure 1, elas-
tography of 32 calcified nodules classified as suspicious
for malignancy by the radiologist revealed 9 nodules as
benign, all of which were confirmed as benign by FNA bi-
opsy. Among 29 indeterminate nodules, elastography
classified 12 nodules as benign, and 11 of the 12 were
confirmed as benign by FNA biopsy. One malignant
nodule with rim calcification was incorrectly classified
by elastography as benign. Four nodules classified as
benign by B-mode US were confirmed as benign by
FNA biopsy. The sensitivity, specificity, PPV and NPV
of elastography in 65 nodules with calcification were
95%, 51.1%, 46.3% and 95.8%, respectively. Twenty-
three benign calcified nodules (51.1% of benign calcified
nodules) were correctly classified by elastography,
whereas only 4 (8.9%) were correctly classified by
B-mode US. Figure 2 are images of two malignant-
looking calcified nodules correctly classified by
elastography.
DISCUSSION
In this study, elastography was found to have a
possible role in the management of calcified thyroid nod-
ules. On the basis of B-mode US only, 61 nodules with
calcification were considered indeterminate or suspicious
for malignancy (Fig. 1). Among the 61 modules, 41
turned out to be benign by FNA biopsy. When the 41 nod-
ules false positive by B-mode US alone were examined
Table 2. Nodule classification with B-mode ultrasound and elastography
Fine-needle aspiration
biopsy result
B-mode ultrasound Elastography
Benign (n 5 43) Indeterminate (n 5 86) Malignant (n 5 67) Benign (n 5 106) Malignant (n 5 90)
Benign (n 5 154) 43 79 32 98 56
Malignant (n 5 42) 0 7 35 8 34
2332 Ultrasound in Medicine and Biology Volume 40, Number 10, 2014by elastography, 20 were correctly re-classified as benign
with a high negative predictive value (95.8%). Of 4
benign nodules correctly classified with B-mode US, 1
was mis-classified as malignant by elastography. Thus,
with the use of elastography on those calcified nodules,
for which B-mode US has low specificity (i.e., 8.9%) in
detecting malignancy, FNA biopsy could have been
avoided in 23 (35.4%) of 65 calcified nodules. In terms
of reducing the number of FNA biopsies, our study found
that elastography had a clinical impact similar to that re-
ported in a previous study that evaluated the usefulness of
elastography in calcified breast lesions (Cho et al. 2009).
In the new management scheme illustrated in
Figure 3, a clinician could rely on elastography findings
in deciding which nodules with calcification should be
referred for FNA biopsy. First, the clinician determines
whether a thyroid nodule is calcified or not. It is well
known that the presence of calcification has good inter-
observer agreement (Choi et al. 2010; Kim et al. 2012;
Park et al. 2010). Even among non-expert readers, good
inter-observer agreement was obtained (Kim et al.
2012). Thus, clinicians would have little difficulty in
identifying calcified nodules by B-mode US imaging
and using elastography in those nodules. If a calcified
nodule has an elastography finding indicative of malig-
nancy, the clinician should refer the patient for FNA bi-
opsy. On the other hand, if US elastography suggestsFig. 1. Classification of 65 calcified nodules with B-mode ultr
needle aspirbenignity, even a nodule with calcification could be fol-
lowed up instead of being aspirated. As the presence of
calcification has been known to have a relatively lower
positive predictive value than other features, resulting in
a substantial number of false positives (Moon et al.
2008), the addition of elastography with high negative
predictive value would be appropriate to reduce the num-
ber of FNA biopsies of benign calcified nodules.
Calcification has been known to influence the stiff-
ness value of thyroid nodules and has resulted in false
positives in previous elastography studies (Asteria et al.
2008; Bojunga et al. 2010; Hong et al. 2009; Rago
et al. 2007). We also found that calcification could lead
to false positives. In analyzing individual benign
nodules, we found that calcification occurred more
frequently in false positives than true negatives (22/55
[40%] vs. 23/99 [23.2%], p 5 0.023). Furthermore, the
amount of calcification (no, micro- and macro-
calcification) was significantly correlated with ECI value
(correlation coefficient 5 0.211, p 5 0.003), suggesting
that a calcified nodule would generally have a larger
ECI value than a nodule without calcification. Among
malignant nodules, the incidence of calcification was
significantly higher in true-positive cases than false-
negative cases (19/34 [55.9%] vs. 1/8 [12.5%],
p 5 0.047). Therefore, if a calcified nodule has a rela-
tively low ECI value, its chance of being malignant wouldasound and elastography. US 5 ultrasound, FNA 5 fine-
ation.
Fig. 2. Representative cases of calcified nodules that were categorized as benign and malignant by elastography. (a, b) A
68-y-old woman presented with a 1.4-cm nodule on the right side of the thyroid. (a) B-Mode ultrasound revealed a hypo-
echoic, spiculated, ovoid to round nodule with both micro- and macro-calcification. (b) Elastography revealed an elastic-
ity contrast index (ECI) of 2.34, which indicated benignity (left: B-mode ultrasound, right: elastography). This nodulewas
confirmed as benign by fine-needle aspiration biopsy. (c, d) A 57-y-old man presented with a 1.3-cm nodule on the right
side of the thyroid. (c) B-Mode ultrasound revealed an iso- to hypo-echoic, ill-defined, taller-than-wide nodule with both
micro- and macro-calcification. (d) Elastography revealed an ECI of 3.93, which indicated malignancy (left: B-mode ul-
trasound, right: elastography). Fine-needle aspiration biopsy revealed a papillary thyroid carcinoma.
Elastography decreases number of FNA biopsies d M.-H. KIM et al. 2333decrease, which might explain the reason why the number
of false-negative cases was small in the analysis of calci-
fied nodules.Fig. 3. How elastography could be used to manage thyroid no
different management algorithms can be applied depending on t
calcification, B-mode ultrasound features could determine whe
cious ultrasound features indicative of malignancy (i.e., mark
micro-calcification and taller-than-wide shape) could define a
calcification, elastography has priority over B-mode ultrasound
raphy, fine-needle aspiration can be avoidThere are several possible reasons that benign nod-
ules have low ECI values despite the presence of calcifi-
cation. One is a difference in stiffness between thedules. When a nodule is detected by B-mode ultrasound,
he absence or presence of calcification. In nodules without
ther fine-needle aspiration is needed. A lack of any suspi-
ed hypo-echogenicity, ill-defined or spiculated margin,
benign nodule by B-mode ultrasound. In nodules with
features. If the nodule is classified as benign by elastog-
ed. FNA 5 fine-needle aspiration.
2334 Ultrasound in Medicine and Biology Volume 40, Number 10, 2014extracellular matrix of malignant nodules and that of
benign nodules, as the extracellular matrix encircling
cancer cells hardens from the beginning of cancer forma-
tion (Huang and Ingber 2005). Elastography could detect
this difference in stiffness between calcified benign and
malignant nodules. Additionally, the dense fibrosis or
condensed colloid found on histopathology could mimic
micro-calcification on B-mode US images (Khoo et al.
2002), and elastography discriminates these features
from real calcification, which makes it able to detect
benign calcified nodules more accurately.
There are several limitations to this study. First, the
number of calcified nodules was relatively small,
although they were derived from a total of 196 nodules
in patients enrolled in a tertiary referral hospital. Further
studies including a large number of calcified thyroid nod-
ules are required to generalize the concept of our study.
Second, inter-observer agreement was not evaluated in
this study, even though it was assessed in our previous
study (Lim et al. 2012). Although the false negativity of
FNA cytology is known to be ,3% (Cibas and Ali
2009), another limitation is that FNA biopsy was per-
formed once on each benign nodule. Even though the
radiologist was very experienced, the interpretation of
B-mode US images by only one radiologist is another
limitation. Lastly, as the cutoff value for the detection
of malignant nodules was inferred from a relatively small
population, validation of the value with a larger patient
population is necessary.CONCLUSIONS
Our study found that intrinsic compression elastog-
raphy has a high negative predictive value (95.8%) in
nodules with calcification. The use of elastography in
65 calcified nodules eliminated the need for FNA biopsy
in 23 (35.4%) benign nodules. Intrinsic compression elas-
tography can be used in conjunction with B-mode US to
reduce the number of FNA biopsies of calcified thyroid
nodules.
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